Brain MRI + Contrast

Contrast-enhanced brain MRI using gadolinium for improved detection and characterisation of tumours, infections, inflammatory lesions, and blood-brain barrier disruption.

The contrast-enhanced brain MRI adds intravenous gadolinium to the standard native protocol, enabling detection of lesions that enhance due to blood-brain barrier breakdown. This is the preferred protocol for tumour characterisation, post-surgical surveillance, suspected CNS infection, and active inflammatory conditions such as neurosarcoidosis. At approximately 109,000 HUF (around EUR 275), the contrast study includes all native sequences plus dynamic post-gadolinium T1-weighted acquisitions in multiple planes. The contrast agent highlights areas of abnormal vascularity and permeability that appear normal on unenhanced imaging. Pre-screening for renal function is performed before contrast administration. Patients with known gadolinium allergy or severe renal impairment are assessed on a case-by-case basis. The examination typically takes 35-40 minutes including the contrast injection pause.